Study links early TNF inhibitor treatment to higher heart disease risk in ankylosing spondylitis patients, with caveats

by American College of RheumatologyCredit: Jean Liew et al, The Association of Early TNF Inhibitor Use with Incident Cardiovascular Events in Ankylosing Spondylitis [abstract]. Arthritis Rheumato

Updated on: June 15,2024 7

Study links early TNF inhibitor treatment to higher heart disease risk in ankylosing spondylitis patients, with caveats

by American College of RheumatologyCredit: Jean Liew et al, The Association of Early TNF Inhibitor Use with Incident Cardiovascular Events in Ankylosing Spondylitis [abstract]. Arthritis Rheumato

Updated on:June 15,2024 7

Secondary structures in DNA are associated with cancer

by Lila Reynolds,Northwestern UniversityCredit: CC0 Public DomainA new cancer study reports that DNA manifested as knot-like folds and third rungs between DNA's two strands may drive cancer

Updated on: April 15,2024 20

Secondary structures in DNA are associated with cancer

by Lila Reynolds,Northwestern UniversityCredit: CC0 Public DomainA new cancer study reports that DNA manifested as knot-like folds and third rungs between DNA's two strands may drive cancer

Updated on:April 15,2024 20

Lasting impact of COVID-19 infection on the immune system

by Elisa Black,University of AdelaideCredit: Unsplash/CC0 Public DomainA world leading research collaboration between SAHMRI, the University of Adelaide, Flinders University, the Women's and

Updated on: April 10,2024 14

Lasting impact of COVID-19 infection on the immune system

by Elisa Black,University of AdelaideCredit: Unsplash/CC0 Public DomainA world leading research collaboration between SAHMRI, the University of Adelaide, Flinders University, the Women's and

Updated on:April 10,2024 14

Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on: April 10,2024 19

Immunity after COVID-19 illness may last at least 1 year

by Ernie MundellLong-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in

Updated on:April 10,2024 19

Three-dimensional label-free morphology of CD8+ T cells as a sepsis biomarker

by Chinese Academy of Sciencesa, Schematic overview of the study workflow. Blood was sampled three times in the sepsis recovery cohort and once in the healthy control cohort. CD8+ T cells were ex

Updated on: April 09,2024 17

Three-dimensional label-free morphology of CD8+ T cells as a sepsis biomarker

by Chinese Academy of Sciencesa, Schematic overview of the study workflow. Blood was sampled three times in the sepsis recovery cohort and once in the healthy control cohort. CD8+ T cells were ex

Updated on:April 09,2024 17

CAR T-cell immunotherapy rids woman of tough-to-treat lupus

by Amy Norton(HealthDay)—In a first, researchers have used genetically tweaked immune system cells to send a woman's severe lupus into remission.The treatment—called CAR T-cell therapy—is already

Updated on: April 09,2024 17

CAR T-cell immunotherapy rids woman of tough-to-treat lupus

by Amy Norton(HealthDay)—In a first, researchers have used genetically tweaked immune system cells to send a woman's severe lupus into remission.The treatment—called CAR T-cell therapy—is already

Updated on:April 09,2024 17

Study offers new insights into how immune cells recognize their enemies

by Gunnar Bartsch,Julius-Maximilians-Universität WürzburgPAg induced Vγ9Vδ2 T cell activation by BTN3A-BTN2A1 composite ligand. Credit:Nature Communications(2023). DOI: 10.1038/s4146

Updated on: January 26,2024 12

Study offers new insights into how immune cells recognize their enemies

by Gunnar Bartsch,Julius-Maximilians-Universität WürzburgPAg induced Vγ9Vδ2 T cell activation by BTN3A-BTN2A1 composite ligand. Credit:Nature Communications(2023). DOI: 10.1038/s4146

Updated on:January 26,2024 12

MAIT cells can be tuned to fight different pathogens via their metabolism, leading to new therapeutic strategies

by La Jolla Institute for ImmunologyCredit: Pixabay/CC0 Public DomainA population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike. Un

Updated on: April 20,2024 16

MAIT cells can be tuned to fight different pathogens via their metabolism, leading to new therapeutic strategies

by La Jolla Institute for ImmunologyCredit: Pixabay/CC0 Public DomainA population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike. Un

Updated on:April 20,2024 16

Knee problems tend to flare up as you age—an orthopedic specialist explains available treatment options

by Angie Brown,The ConversationCredit: CC0 Public DomainKnee injuries are common in athletes, accounting for41% of all athletic injuries. But knee injuries aren't limited to competitiv

Updated on: November 21,2024 0

Knee problems tend to flare up as you age—an orthopedic specialist explains available treatment options

by Angie Brown,The ConversationCredit: CC0 Public DomainKnee injuries are common in athletes, accounting for41% of all athletic injuries. But knee injuries aren't limited to competitiv

Updated on:November 21,2024 0

Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study

Updated on: March 28,2024 17

Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that in one study

Updated on:March 28,2024 17

Gut microbiome: Meet Roseburia intestinalis—the energy-producing bacterium that helps us fight against disease

by Conor Meehan,The ConversationCredit: Pixabay/CC0 Public DomainThe hundreds of species of microorganisms that comprise the microbiome all have different, unique roles.One of the important func

Updated on: March 27,2024 0

Gut microbiome: Meet Roseburia intestinalis—the energy-producing bacterium that helps us fight against disease

by Conor Meehan,The ConversationCredit: Pixabay/CC0 Public DomainThe hundreds of species of microorganisms that comprise the microbiome all have different, unique roles.One of the important func

Updated on:March 27,2024 0

Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on: March 19,2024 13

Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on:March 19,2024 13